Skip to main content

Peer Review reports

From: An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir

Original Submission
27 Feb 2018 Submitted Original manuscript
3 Apr 2018 Author responded Author comments - Eva Agnes Laker Odongpiny
Resubmission - Version 2
3 Apr 2018 Submitted Manuscript version 2
20 May 2018 Reviewed Reviewer Report - NIPAM SHAH
19 Jun 2018 Reviewed Reviewer Report - Rupak Shivakoti
5 Aug 2018 Reviewed Reviewer Report - Salome Charalambous
19 Nov 2018 Author responded Author comments - Eva Agnes Laker Odongpiny
Resubmission - Version 3
19 Nov 2018 Submitted Manuscript version 3
29 Jan 2019 Reviewed Reviewer Report - Rupak Shivakoti
12 Mar 2019 Author responded Author comments - Eva Agnes Laker Odongpiny
Resubmission - Version 4
12 Mar 2019 Submitted Manuscript version 4
Publishing
15 Mar 2019 Editorially accepted
25 Mar 2019 Article published 10.1186/s12879-019-3907-5

You can find further information about peer review here.

Back to article page